Harmonized Index of Consumer Prices: Pharmaceutical Products for Czech Republic
CP0611CZM086NEST • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
135.20
Year-over-Year Change
0.82%
Date Range
12/1/1999 - 6/1/2025
Summary
The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products in the Czech Republic tracks changes in the prices of pharmaceuticals and related medical goods. This metric is crucial for policymakers monitoring inflation and consumer purchasing power.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The HICP for Pharmaceutical Products measures the price changes of a basket of pharmaceutical and medical products in the Czech Republic. It is a key indicator used by economists and central bankers to assess cost-of-living trends and inflationary pressures in the healthcare sector.
Methodology
The data is collected through surveys of retail establishments and aggregated by the Czech Statistical Office.
Historical Context
This index provides important context for the Czech National Bank's monetary policy decisions.
Key Facts
- The HICP for Pharmaceutical Products has a base year of 2015.
- Prices are monitored across a variety of pharmaceutical categories.
- This index is published monthly by the Czech Statistical Office.
FAQs
Q: What does this economic trend measure?
A: The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products in the Czech Republic tracks changes in the prices of pharmaceuticals and related medical goods.
Q: Why is this trend relevant for users or analysts?
A: This metric is crucial for policymakers monitoring inflation and consumer purchasing power in the healthcare sector.
Q: How is this data collected or calculated?
A: The data is collected through surveys of retail establishments and aggregated by the Czech Statistical Office.
Q: How is this trend used in economic policy?
A: The HICP for Pharmaceutical Products provides important context for the Czech National Bank's monetary policy decisions.
Q: Are there update delays or limitations?
A: This index is published monthly by the Czech Statistical Office.
Related Trends
Orders: Construction: Permits Issued: Dwellings and Residential Buildings for Czech Republic
ODCNPI03CZA657S
Harmonized Index of Consumer Prices: Gas for Czech Republic
CP0452CZM086NEST
Consumer Price Indices (CPIs, HICPs), COICOP 1999: Consumer Price Index: Energy for Czechia
CPGREN01CZQ659N
Number of Identified Exporters to Czech Republic from Missouri
MOCZEA475SCEN
Consumer Price Indices (CPIs, HICPs), COICOP 1999: Consumer Price Index: All Items Non-Food Non-Energy for Czechia
CPGRLE01CZM659N
Cash surplus/deficit (% of GDP) for the Czech Republic
CASHBLCZA188A
Citation
U.S. Federal Reserve, Harmonized Index of Consumer Prices: Pharmaceutical Products for Czech Republic (CP0611CZM086NEST), retrieved from FRED.